Viral cross talk: Intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver

被引:179
作者
Guidotti, LG
Borrow, P
Hobbs, MV
Matzke, B
Gresser, I
Oldstone, MBA
Chisari, FV
机构
[1] Scripps Res Inst, RES INST, DEPT MOLEC & EXPTL MED, LA JOLLA, CA 92037 USA
[2] Scripps Res Inst, RES INST, DEPT NEUROPHARMACOL, LA JOLLA, CA 92037 USA
[3] Scripps Res Inst, RES INST, DEPT IMMUNOL, LA JOLLA, CA 92037 USA
[4] UNIV PARMA, IST PATOL GEN, I-43100 PARMA, ITALY
[5] INST RECH SCI CANC, LAB VIRAL ONCOL, F-94802 VILLEJUIF, FRANCE
关键词
D O I
10.1073/pnas.93.10.4589
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Hepatitis B virus (HBV) infection is thought to be controlled by virus-specific cytotoxic T lymphocytes (CTL). We have recently shown that HBV-specific CTL can abolish HBV replication noncytopathically in the liver of transgenic mice by secreting tumor necrosis factor alpha (TNF-alpha) and interferon gamma (IFN-gamma) after antigen recognition. We now demonstrate that hepatocellular HBV replication is also abolished noncytopathically during lymphocytic choriomeningitis virus (LCMV) infection, and we show that this process is mediated by TNF-alpha and IFN-alpha/beta produced by LCMV-infected hepatic macrophages. These results confirm the ability of these inflammatory cytokines to abolish HBV replication; they elucidate the mechanism likely to be responsible for clearance of HBV in chronically infected patients who become superinfected by other hepatotropic viruses; they suggest that pharmacological activation of intrahepatic macrophages may have therapeutic value in chronic HBV infection; and they raise the possibility that conceptually similar events may be operative in other viral infections as well.
引用
收藏
页码:4589 / 4594
页数:6
相关论文
共 39 条
[1]  
ALCAMI A, 1995, J VIROL, V69, P4633
[2]   F4-80, A MONOCLONAL-ANTIBODY DIRECTED SPECIFICALLY AGAINST THE MOUSE MACROPHAGE [J].
AUSTYN, JM ;
GORDON, S .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1981, 11 (10) :805-815
[3]   MONOCLONAL-ANTIBODIES TO LYMPHOCYTIC CHORIOMENINGITIS AND PICHINDE VIRUSES - GENERATION, CHARACTERIZATION, AND CROSS-REACTIVITY WITH OTHER ARENAVIRUSES [J].
BUCHMEIER, MJ ;
LEWICKI, HA ;
TOMORI, O ;
OLDSTONE, MBA .
VIROLOGY, 1981, 113 (01) :73-85
[4]   BIOLOGY OF CLONED CYTO-TOXIC LYMPHOCYTES-T SPECIFIC FOR LYMPHOCYTIC CHORIOMENINGITIS VIRUS - CLEARANCE OF VIRUS INVIVO [J].
BYRNE, JA ;
OLDSTONE, MBA .
JOURNAL OF VIROLOGY, 1984, 51 (03) :682-686
[5]  
CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333
[6]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[7]   ACUTE TYPE-A HEPATITIS DURING CHRONIC HEPATITIS-B VIRUS-INFECTION - ASSOCIATION OF DEPRESSED HEPATITIS-B VIRUS-REPLICATION WITH APPEARANCE OF ENDOGENOUS ALPHA-INTERFERON [J].
DAVIS, GL ;
HOOFNAGLE, JH ;
WAGGONER, JG .
JOURNAL OF MEDICAL VIROLOGY, 1984, 14 (02) :141-147
[8]   GENOMIC AND BIOLOGICAL VARIATION AMONG COMMONLY USED LYMPHOCYTIC CHORIOMENINGITIS VIRUS-STRAINS [J].
DUTKO, FJ ;
OLDSTONE, MBA .
JOURNAL OF GENERAL VIROLOGY, 1983, 64 (AUG) :1689-1698
[9]   EXPRESSION OF THE TERMINAL PROTEIN REGION OF HEPATITIS-B VIRUS INHIBITS CELLULAR-RESPONSES TO INTERFERON-ALPHA AND INTERFERON-GAMMA AND DOUBLE-STRANDED-RNA [J].
FOSTER, GR ;
ACKRILL, AM ;
GOLDIN, RD ;
KERR, IM ;
THOMAS, HC ;
STARK, GR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (07) :2888-2892
[10]   THE MOLECULAR-BIOLOGY OF THE HEPATITIS-B VIRUSES [J].
GANEM, D ;
VARMUS, HE .
ANNUAL REVIEW OF BIOCHEMISTRY, 1987, 56 :651-693